Exponent Private Equity has agreed to acquire The BBI Diagnostics Group for $164 million, aiming to leverage BBI's strengths in the growing diagnostics market.

Target Company Overview

Exponent Private Equity has entered into an agreement to acquire The BBI Diagnostics Group (BBI) from Alere Inc. for $164 million. Established in 1986, BBI specializes in providing products and technologies for the diagnostic, healthcare, research, defense, and food industries. The company became publicly listed on London's AIM market in 2004 and was acquired by Alere (formerly known as Inverness Medical Innovations) in 2008. BBI is headquartered in Cardiff, South Wales, and employs approximately 470 personnel across various global locations.

BBI has earned a reputation as a reliable partner for some of the most prestigious diagnostic and healthcare organizations globally over the past 25 years. Founded on the excellence of gold diagnostic reagents, BBI has expanded its offerings to include more than 1,000 products and a wide array of contract development and manufacturing services.

Industry Overview in the United Kingdom

The United Kingdom boasts a well-established healthcare and diagnostics industry, characterized by continuous innovation and a commitment to quality. The sector is a vital contributor to the UK economy, with significant investments pouring into r